Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

Alcon

Status and phase: Withdrawn; Phase 4

Conditions: Visual Outcomes

Treatments: Device: Acrysof ReSTOR multifocal IOL

Study type: Interventional

Funder types: Industry

Identifiers

NCT00758940

HK-Restor-YIU-01

Details and patient eligibility

About

An unmasked trial after bilateral implantation of AcrySof® ReSTOR®, SA60D3 IOL . Enrolled are at least 30 patients or as much as possible from the doctor's clinical practice perspective. 6 months follow-up after IOL implant in the 2nd eye

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Able to complete all required postoperative visits; Planned cataract removal by phaco; 21 years of age or older, either gender or any race; potential postoperative visual acuity of 20/20; astigmatism ≦1.0D measured by keratometry in study eye(s);clear int

Exclusion criteria

• Signs of capsular tear, significant anterior chamber hyphema;zonular rupture; corneal pathology and refractive surgery;hypercritical patient; patients with unrealistic expectations in post-op VA; happy to wear glasses;occupational night drivers

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

1

Experimental group

Description:

Acrysof ReSTOR multifocal IOL

Treatment:

Device: Acrysof ReSTOR multifocal IOL